Originally published by Capital News

top

July 15, 2025

3mo ago

WHO recommends twice-yearly injectable lenacapavir for HIV prevention

LEN now joins other WHO-recommended PrEP options—such as daily oral PrEP, injectable cabotegravir, and the dapivirine vaginal ring—as part of a growing arsenal of tools to end the HIV epidemic. - Kenya breaking news | Kenya news today | Capitalfm.co.ke..

✨ Key Highlights

The World Health Organization (WHO) has recommended the use of injectable lenacapavir (LEN) twice a year as an innovative pre-exposure prophylaxis (PrEP) for HIV prevention, announced during the 13th International AIDS Society Conference in Kigali, Rwanda.

1.3 million new HIV infections were recorded in 2024, highlighting the need for effective prevention methods.
Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, emphasized that LEN is a transformative option for those at risk.
The guidelines simplify testing protocols, promoting access to long-acting PrEP via community-based delivery.

Continue Reading

Read the complete article from Capital News

📰 Read Full Article

Part of the Day's Coverage

Health Initiatives and Concerns in Kenya

Kenya's early rollout of injectable HIV prevention drug Lenacapavir and concerns over mysterious disease in Mombasa.

Kenya picked for early rollout of injectable HIV prevention drug Lenacapavir

KBC Top Stories

Kenya to roll out long-acting injectable HIV PrEP Lenacapavir by Jan 2026

Capital News

Concern as Mysterious Disease Kills 4 in Mombasa

Kenyans

4 stories in this topic

View Full Coverage

Related News

Video

Life-saving HIV prevention injection to retail at Sh5,000, down from Sh4M yearly cost

KTN News (Youtube)

3w ago

entertainment2w ago

Millions in LMICs to Access Affordable HIV Prevention Injection

Millions in low- and middle-income countries (LMICs) are set to gain access to an affordable, long-acting injectable HIV prevention drug called lenacapavir, hailed as a potential game-changer. This breakthrough follows new pricing agreements announced in New York on September 24, 2025.

Ghafla! (Entertainment)

📰 Read Full Story

top3w ago

Gates Foundation Partners with Indian Manufacturer to Make HIV Prevention Injection Affordable

The Gates Foundation has partnered with Indian manufacturer Hetero Labs to make a low-cost, generic version of lenacapavir, the world’s first twice-yearly injectable HIV prevention drug, accessible to millions in low- and middle-income countries.